EKR Therapeutics actively seeks to acquire, in-license, and distribute proprietary products for the acute setting, including oncology supportive care therapeutics. To this end, we have brought together a highly cohesive team of pharmaceutical and business professionals who have successfully engineered several deal structures and who possess a track record of identifying, acquiring, and maximizing the therapeutic and commercial potentials of products in our targeted market space. We approach all prospective partnership and acquisition deals with a philosophy that encompasses the common goals of EKR and our partners. Additionally, we are organized for speed in closing deals and are well positioned to exploit product growth opportunities driven by our in-house expertise in acute care, the strength of our sales force, and our dedication to customer service and medical education. If you are looking for a North American sales and marketing partner that is committed to and structured for pre-eminence as a provider of acute care and oncology supportive care products, we should talk. To learn how EKR Therapeutics can be your partner of choice and to discuss potential partnering opportunities, please contact: Darren Pincus
|
 |
|
|
|||||||||||||||
 |
|
|
|||||||||||||||
 |
 |
|
|||||||||||||||
| » Business Development |
